These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18633255)

  • 1. [Bolus injection of vinorelbine reduces incidence of local venous toxicity in patients with non-small cell lung cancer and breast cancer].
    Asako E; Maruyama T; Yamada M; Yoshizaki N; Tsujimura H
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1163-7. PubMed ID: 18633255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consideration of preventive free-flowing IV infusion method for vinorelbine].
    Suga Y; Hara Y; Hashimoto H; Nishigami J; Shimizu M; Akasaka H; Hayashi K; Yonejima M; Nakamura M; Inokuchi M; Kasahara K; Nishimura G; Miyamoto K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1255-7. PubMed ID: 17687207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Apr; 34(4):206-9. PubMed ID: 15121757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine).
    Rittenberg CN; Gralla RJ; Rehmeyer TA
    Oncol Nurs Forum; 1995 May; 22(4):707-10. PubMed ID: 7675673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].
    Nakayama S; Matsubara N; Sakai T; Aso N
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554
    [No Abstract]   [Full Text] [Related]  

  • 7. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
    Goa KL; Faulds D
    Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of phlebitis caused by vinorelbine chemotherapy in outpatients with breast cancer].
    Yokota Y; Suzuki T; Narahashi T; Takizawa J; Kojima M; Shimada R
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1525-9. PubMed ID: 18799905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis of toxic effects on the peripheral venous system associated with intravenous administration of vinorelbine].
    Cinieri S; Orlando L; Cocorocchio E; Munzone E; Catania C; Brunetti C; Rocca A; Martinelli G; Nolè F
    Clin Ter; 1999; 150(3):225-9. PubMed ID: 10528436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention.
    Yamada T; Egashira N; Watanabe H; Nagata K; Yano T; Nonaka T; Oishi R
    Support Care Cancer; 2012 Jul; 20(7):1549-53. PubMed ID: 21805382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.
    Carabante-Ocón F; Cobo-Dols M; Benavides-Orgaz M; Gil-Calle S; Alés-Díaz I; Bretón-García JJ; Villar-Chamorro E; Montesa-Pino A; Alcalde-García J; Gutiérrez-Calderón V
    Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of vinorelbine phlebitis with cimetidine. A two-step design study.
    Vassilomanolakis M; Koumakis G; Barbounis V; Orphanos G; Efremidis A
    Support Care Cancer; 2001 Mar; 9(2):108-11. PubMed ID: 11305068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.
    Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J
    J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
    Aapro MS
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine and venous irritation: optimal parenteral administration.
    de Lemos ML
    J Oncol Pharm Pract; 2005 Jun; 11(2):79-81. PubMed ID: 16460608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine tartrate: a promising new chemotherapeutic agent.
    Baldwin PD
    J Intraven Nurs; 1996; 19(1):16-27. PubMed ID: 8708838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
    Wakelee HA; Middleton G; Dunlop D; Ramlau R; Leighl N; Hao D; Lopez-Anaya A; Zatloukal P; Jacobs CD
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):815-24. PubMed ID: 22057854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.
    Alici S; Coskun U; Alkis N; Sevinc A; Dane F; Gumus M; Ozkan M; Kaya AO; Celenkoglu G; Buyukberber S; Altunbas M; Benekli M;
    Asian Pac J Cancer Prev; 2009; 10(6):1051-5. PubMed ID: 20192582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.